Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
November 1979

Pulmonary Blastomycosis in ChildrenAmphotericin B Therapy and a Review

Author Affiliations

From the Departments of Pediatrics (Drs Chesney, Gourley, and Moffet) and Radiology (Dr Peters), University of Wisconsin School of Medicine, Madison, Wis.

Am J Dis Child. 1979;133(11):1134-1139. doi:10.1001/archpedi.1979.02130110042005

• Two children, aged 3 months and 4 years, respectively, were treated with ten weeks of amphotericin B for culture proved pulmonary blastomycosis. Organisms were easily demonstrated in nasopharyngeal or sputum specimens on admission. Although organisms were present until the 12th and 19th days of therapy, respectively, they were viable through only the seventh and 12th days of therapy. Both patients had thrombophlebitis, anemia, neutropenia, hypokalemia, fever, and vomiting develop during therapy. The less toxic drug hydroxystilbamidine isethionate, given for only 17 to 30 days, has been used successfully in at least six previously reported cases. Long courses of amphotericin B therapy may not be necessary for the treatment of pulmonary blastomycosis in selected children.

(Am J Dis Child 133:1134-1139, 1979)